Schonfeld Strategic Advisors LLC Mirum Pharmaceuticals, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 22,244 shares of MIRM stock, worth $882,864. This represents 0.01% of its overall portfolio holdings.
Number of Shares
22,244Holding current value
$882,864% of portfolio
0.01%Shares
6 transactions
Others Institutions Holding MIRM
# of Institutions
174Shares Held
54.2MCall Options Held
96.1KPut Options Held
54.8K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$258 Million13.09% of portfolio
-
Janus Henderson Group PLC London, X04.99MShares$198 Million0.09% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$173 Million4.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.61MShares$143 Million2.18% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$129 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.46B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...